temozolomide 250 MG Oral Capsule
1 INDICATIONS AND USAGE Temozolomide capsules are an alkylating drug indicated for the treatment of adults with: Newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. ( 1.1 ) Anaplastic astrocytoma. ( 1.2 ) Adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma. ( 1.2 ) Treatment of adults with refractory anaplastic astrocytoma. ( 1.2 ) 1.1 Newly Diagnosed Glioblastoma Temozolomide capsules are indicated for the treatment of adults with newly diagnosed glioblastoma, concomitantly with radiotherapy and then as maintenance treatment. 1.2 Anaplastic Astrocytoma Temozolomide capsules are indicated for the: adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma; treatment of adults with refractory anaplastic astrocytoma.
Amneal Pharmaceuticals LLC
CAPSULE WHITE AMNEAL 806
Related Pills
temozolomide 140 MG Oral Capsule
Amneal Pharmaceuticals LLC
temozolomide 180 MG Oral Capsule
Amneal Pharmaceuticals LLC
temozolomide 5 MG Oral Capsule
Amneal Pharmaceuticals LLC
temozolomide 20 MG Oral Capsule
Amneal Pharmaceuticals LLC
temozolomide 100 MG Oral Capsule
Amneal Pharmaceuticals LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
TEMOZOLOMIDE capsules USP, is a hazardous drug. Follow applicable special handling and disposal procedures. 1
TEMOZOLOMIDE capsules USP, 5 mg are supplied as size “3” hard gelatin capsules with green opaque color caps imprinted “AMNEAL” and white opaque color bodies imprinted “801” with black ink. They are supplied as follows: Bottles of 5: NDC 65162-801-51 Bottles of 14: NDC 65162-801-14
TEMOZOLOMIDE capsules USP, 20 mg are supplied as size “2” hard gelatin capsules with yellow opaque color caps imprinted “AMNEAL” and white opaque color bodies imprinted “802” with black ink. They are supplied as follows: Bottles of 5: NDC 65162-802-51 Bottles of 14: NDC 65162-802-14
TEMOZOLOMIDE capsules USP, 100 mg are supplied as size “1” hard gelatin capsules with pink opaque color caps imprinted “AMNEAL” and white opaque color bodies imprinted “803” with black ink. They are supplied as follows: Bottles of 5: NDC 65162-803-51 Bottles of 14: NDC 65162-803-14
TEMOZOLOMIDE capsules USP, 140 mg are supplied as size “0” hard gelatin capsules with blue opaque color caps imprinted “AMNEAL” and white opaque color bodies imprinted “804” with black ink. They are supplied as follows: Bottles of 5: NDC 65162-804-51 Bottles of 14: NDC 65162-804-14
TEMOZOLOMIDE capsules USP, 180 mg are supplied as size “0” hard gelatin capsules with red opaque color caps imprinted “AMNEAL” and white opaque color bodies imprinted “805” with black ink. They are supplied as follows: Bottles of 5: NDC 65162-805-51 Bottles of 14: NDC 65162-805-14
TEMOZOLOMIDE capsules USP, 250 mg are supplied as size “0” hard gelatin capsules with white opaque color caps imprinted “AMNEAL” and white opaque color bodies imprinted “806” with black ink. They are supplied as follows: Bottles of 5: NDC 65162-806-51 Store
TEMOZOLOMIDE capsules USP, at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
More pills like CAPSULE AMNEAL 806